E 1101
Alternative Names: E 1100Latest Information Update: 20 Jun 2002
Price :
$50 *
At a glance
- Originator Eisai Co Ltd
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 14 Aug 1995 Phase-II clinical trials for Bacterial infections in Japan (PO)